Sep 9 2009
From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.
Mirus has expanded its transfection expertise with the development of a high performance, animal-free, broad spectrum DNA transfection reagent which offers users:
- Superior Performance--TransIT(R)-2020 outperforms FuGENE(R) HD, Lipofectamine(TM) 2000 and Lipofectamine(TM) 2000 CD in many cell types.
- Broad Spectrum DNA Delivery--Achieve high transgene expression in many cell types, including hard to transfect cells.
- Animal Origin free-- TransIT(R)-2020 provides high performance with maximum compatibility.
- Scientifically Proven--Developed by Mirus Bio scientists with over 15 years of gene delivery expertise.
Novel immune cell therapy may be a promising strategy for combating HBV infection